Iranian Journal of Diabetes and Obesity
Shahid Sadoughi University Of Medical Sciences
Sun, Nov 24, 2024
[Archive]
Volume 15, Issue 2 (6-2023)
IJDO 2023, 15(2): 66-72 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Entezari Z, Injinari N, Vakili M, Namiranian N. Identification of Factors Related to Sexual Dysfunction in Type 2 Diabetic Women. IJDO 2023; 15 (2) :66-72
URL: http://ijdo.ssu.ac.ir/article-1-788-en.html
URL: http://ijdo.ssu.ac.ir/article-1-788-en.html
Department of Community and Preventive Medicine, Health Monitoring Research Center, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Abstract: (625 Views)
Objective: Type 2 diabetes mellitus (T2DM) is one of the most common metabolic diseases among women. Sexual dysfunction (SD) is a complication in patients with T2DM that has received less attention among women than men. This study aimed to assess the factors related to female SD in T2DM patients.
Materials and Methods: 120 women with T2DM who referred to the Yazd Diabetes Center in 2019-2020 were selected. Female sexual function index (FSFI) as a valid questionnaire was used. Neuropathy, nephropathy, retinopathy, hyperlipidemia, hypertension, diabetes medication, Hb1Ac, age, and duration of diabetes as factors related to SD were assessed. The T-test and chi-square tests were used to analyze the data by SPSS 22 software.
Results: The mean age of participants was 48.40 (±7.35). The SD was impaired in 85.8% of subjects and none of the participants showed a level of good function in any of the sexual domains. There was a significant relationship between SD and neuropathy (P= 0.005), hyperlipidemia (P= 0.007), hypertension (P= 0.015), diabetes medication (P= 0.005), age (P= 0.0001), and duration of diabetes (P= 0.0001). There was no significant relationship between SD and retinopathy (P= 0.565), nephropathy (P= 0.288), and Hb1Ac (P= 0.92).
Conclusion: The frequency of SD in females with T2DM remarkably was high and the factors including age, duration of diabetes, diabetes medication, hypertension, hyperlipidemia, and neuropathy were identified as factors related to SD.
Materials and Methods: 120 women with T2DM who referred to the Yazd Diabetes Center in 2019-2020 were selected. Female sexual function index (FSFI) as a valid questionnaire was used. Neuropathy, nephropathy, retinopathy, hyperlipidemia, hypertension, diabetes medication, Hb1Ac, age, and duration of diabetes as factors related to SD were assessed. The T-test and chi-square tests were used to analyze the data by SPSS 22 software.
Results: The mean age of participants was 48.40 (±7.35). The SD was impaired in 85.8% of subjects and none of the participants showed a level of good function in any of the sexual domains. There was a significant relationship between SD and neuropathy (P= 0.005), hyperlipidemia (P= 0.007), hypertension (P= 0.015), diabetes medication (P= 0.005), age (P= 0.0001), and duration of diabetes (P= 0.0001). There was no significant relationship between SD and retinopathy (P= 0.565), nephropathy (P= 0.288), and Hb1Ac (P= 0.92).
Conclusion: The frequency of SD in females with T2DM remarkably was high and the factors including age, duration of diabetes, diabetes medication, hypertension, hyperlipidemia, and neuropathy were identified as factors related to SD.
Type of Study: Research |
Subject:
Special
Received: 2023/01/8 | Accepted: 2023/04/8 | Published: 2023/06/20
Received: 2023/01/8 | Accepted: 2023/04/8 | Published: 2023/06/20
References
1. Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, et al. Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Frontiers in endocrinology. 2017;8:6. [DOI:10.3389/fendo.2017.00006]
2. Mehrabbeik A, Namiranian N, Azizi R, Meybody MA, Shariati M, Kohani HA. Investigation of Association Between Insulin Injection Technique and Blood Glucose Control in Patients with Type 2 Diabetes. International Journal of Endocrinology and Metabolism. 2022;20(4):1-7. [DOI:10.5812/ijem-128392]
3. Firouzkouhi M, Abdollahimohammad A. Lived Experiences of Type 2 Diabetes with Irreversible Complications: A Qualitative Research. Iranian journal of diabetes and obesity. 2022;14(3):29-35. [DOI:10.18502/ijdo.v14i3.10744]
4. Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of diabetes 2017. Journal of diabetes research. 2018;2018. [DOI:10.1155/2018/3086167]
5. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019;157:107843. [DOI:10.1016/j.diabres.2019.107843]
6. Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani Tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC public health. 2020;20:1-9. [DOI:10.1186/s12889-020-8267-y]
7. Samimagham HR, Farshidi H, Nikparvar M, Arabi M, Tamaddondar M, Ghasemzadeh M, et al. The association of glomerular filtration rate with coronary artery disease in type 2 diabetic patients. Iranian Journal of Diabetes and Obesity. 2020;12(3):126-31. [DOI:10.18502/ijdo.v12i3.4444]
8. Ghadiri-Anar A, Kheirollahi K, Hazar N, Namiranian N, Akhondi-Meybody M, Mayani MA. Frequency of Oral Manifestation in Diabetic Patients in Yazd 2016-2017. Iranian journal of diabetes and obesity. 2020 ;12(2):63-8. [DOI:10.18502/ijdo.v12i2.4043]
9. Andreoulakis E, Hyphantis T, Kandylis D, Iacovides A. Depression in diabetes mellitus: a comprehensive review. Hippokratia. 2012 Jul;16(3):205-14.
10. Holt RI. Groot M de, Golden SH. Diabetes and depression. Curr Diab Rep. 2014;14(6):491. [DOI:10.1007/s11892-014-0491-3]
11. Ozcan S, Sahin NH, Bilgic D, Yilmaz SD. Is sexual dysfunction associated with diabetes control and related factors in women with diabetes?. Sexuality and Disability. 2011;29:251-61. [DOI:10.1007/s11195-011-9209-5]
12. Flynn KE, Lin L, Bruner DW, Cyranowski JM, Hahn EA, Jeffery DD, et al. Sexual satisfaction and the importance of sexual health to quality of life throughout the life course of US adults. The journal of sexual medicine. 2016;13(11):1642-50. [DOI:10.1016/j.jsxm.2016.08.011]
13. Rosen, C. Brown, J. Heiman, S. Leiblum, C. Meston, R. Shabsigh, D. et al. D'Agostino R. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. Journal of sex & marital therapy. 2000;26(2):191-205. [DOI:10.1080/009262300278597]
14. Ziaei-Rad M, Vahdaninia M, Montazeri A. Sexual dysfunctions in patients with diabetes: a study from Iran. Reproductive Biology and Endocrinology. 2010;8:1-8. [DOI:10.1186/1477-7827-8-50]
15. Ezeani I, Onyeonoro U, Ugwu E. Evaluation of female sexual function in persons with type 2 diabetes mellitus seen in a tertiary hospital in Southeast Nigeria with emphasis on its frequency and predictors. Journal of sex & marital therapy. 2020;46(2):170-6. [DOI:10.1080/0092623X.2019.1654583]
16. Rahmanian E, Salari N, Mohammadi M, Jalali R. Evaluation of sexual dysfunction and female sexual dysfunction indicators in women with type 2 diabetes: a systematic review and meta-analysis. Diabetology & metabolic syndrome. 2019;11:1-7. [DOI:10.1186/s13098-019-0469-z]
17. Bahar A, Elyasi F, Moosazadeh M, Afradi G, Kashi Z. Sexual dysfunction in men with type II diabetes. Casp J Intern Med [Internet]. 2020 [cited 2020 Nov 10];11(3):295-303. Available from: /pmc/articles/PMC7442469/?report=abstract
18. Alikamali M, Khodabandeh S, Motesaddi M. Sexual dysfunction in males and females with type 2 diabetes referring to healthcare centers of Zarand, Kerman: a cross-sectional study. Shiraz E-Medical Journal. 2019;20(8). [DOI:10.5812/semj.84268]
19. Kumar S, Singh RK, Bhardwaj TR. Therapeutic role of nitric oxide as emerging molecule. Biomedicine & Pharmacotherapy. 2017;85:182-201. [DOI:10.1016/j.biopha.2016.11.125]
20. Abdaly MS, Azizi MS, Wijaya IP, Nugroho P, Purnamasari D. Subclinical Atherosclerosis in Young Adult Population with First Degree Relatives of Type 2 Diabetes Mellitus. Acta Med Indones. 2019;51(2):169-76.
21. Gandhi J, Dagur G, Warren K. Effect of diabetes mellitus on sexual arousal and intercourse. Transl Biomed. 2016;7(2):2-5. [DOI:10.21767/2172-0479.100057]
22. Y Yenice MG, Danacıoğlu YO, Mert M, Karakaya P, Seker KG, Akkaş F, et al. Evaluation of factors affecting sexual dysfunction in female patients with diabetes mellitus. Archives of Endocrinology and Metabolism. 2020;64:319-25. [DOI:10.20945/2359-3997000000238]
23. Schulster ML, Liang SE, Najari BB. Metabolic syndrome and sexual dysfunction. Current Opinion in Urology. 2017;27(5):435-40. [DOI:10.1097/MOU.0000000000000426]
24. Xu Y, Zhang Y, Yang Y, Liu L, Chen Y, Liu X. Prevalence and correlates of erectile dysfunction in type 2 diabetic men: a population-based cross-sectional study in Chinese men. International journal of impotence research. 2019;31(1):9-14. [DOI:10.1038/s41443-018-0060-4]
25. Elyasi F, Kashi Z, Tasfieh B, Bahar A, Khademloo M. Sexual dysfunction in women with type 2 diabetes mellitus. Iranian journal of medical sciences. 2015 ;40(3):206-13.
26. Oztürk M, Yildiz S, Gonen MS. Sexual Function Disorders in Type 2 Diabetic Women; Cross-Sectional Study. Eastern Journal of Medicine. 2020;25(4):552-7. [DOI:10.5505/ejm.2020.87369]
27. Tuncel E, Durgun O, Peynirci H, Ersoy C. Sexual dysfunction in female patients with type 2 diabetes mellitus: a cross-sectional single-centre study among Turkish patients. Human fertility. 2017;20(3):192-9. [DOI:10.1080/14647273.2016.1266039]
28. Barbagallo F, Mongioì LM, Cannarella R, La Vignera S, Condorelli RA, Calogero AE. Sexual dysfunction in diabetic women: an update on current knowledge. Diabetology. 2020;1(1):11-21. [DOI:10.3390/diabetology1010002]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
